The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Medica Group Plc

4 Jul 2023 14:53

Samson Rock Capital LLP - Form 8.3 - Medica Group Plc

Samson Rock Capital LLP - Form 8.3 - Medica Group Plc

PR Newswire

London, July 4

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:SAMSON ROCK CAPITAL LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeMEDICA GROUP PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 03/07/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:ORDINARY 0.2p
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:12,424,67110.09
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:12,424,67110.09

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (includin directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

 (b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
0.2p ORDINARYEQUITY SWAPINCREASING A LONG POSITION4,270211 GBp

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:04/07/2023
Contact name:Trishawna Simpson
Telephone number*:02039941800

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Aug 20225:33 pmRNSHolding(s) in Company
1st Aug 20222:58 pmRNSIssue of Equity and Total Voting Rights
1st Aug 202212:13 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSTrading update and full year outlook
25th Jul 20222:30 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSBlock Listing Application
28th Jun 202212:46 pmRNSHolding(s) in Company
27th Jun 20221:58 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
27th May 20225:22 pmRNSNotice of AGM
19th May 20227:00 amRNSHolding(s) in Company
12th Apr 202211:29 amRNSPublication of Annual Report
4th Apr 20227:00 amRNSResults for the year ended 31 December 2021
9th Mar 20224:40 pmRNSSecond Price Monitoring Extn
9th Mar 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20224:35 pmRNSPrice Monitoring Extension
16th Feb 202211:22 amRNSHolding(s) in Company
4th Feb 20223:05 pmRNSNotification of Major Holdings
28th Jan 20222:02 pmRNSNotification of Major Holdings
27th Jan 20221:19 pmRNSNotification of Major Shareholdings
26th Jan 20227:00 amRNSTrading and Business Update
24th Jan 20228:00 amRNSHolding(s) in Company
7th Jan 20227:00 amRNSAppointment of Numis as Joint Broker
5th Jan 20223:21 pmRNSBlock listing Interim Review
30th Dec 20213:48 pmRNSIssue of Equity
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20218:00 amRNSHolding(s) in Company
25th Nov 20218:00 amRNSHolding(s) in Company
2nd Nov 202110:01 amRNSDirector/PDMR Shareholding
29th Oct 20219:18 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSIssue of Equity
29th Sep 20217:00 amRNSRecord Date for Dividend – Correction
27th Sep 20217:00 amRNSInterim results for the six months to 30 June 2021
17th Sep 20211:47 pmRNSHolding(s) in Company
7th Sep 20217:00 amRNSCapital Markets Day
26th Aug 202110:17 amRNSHolding(s) in Company
17th Aug 202111:20 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSIssue of Equity and Total Voting Rights
22nd Jul 20217:00 amRNSTrading and business update
8th Jul 20219:28 amRNSHolding(s) in Company
5th Jul 202110:49 amRNSBlock Listing Application
22nd Jun 20211:45 pmRNSDirector/PDMR Shareholding
21st Jun 20217:00 amRNSDirector/PDMR Shareholding
16th Jun 20211:00 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
15th Jun 20217:40 amRNSDirector Declaration
15th Jun 20217:00 amRNSMedica appoints Barbara Moorhouse as NED
11th Jun 20214:34 pmRNSDirector/PDMR Shareholding
9th Jun 20219:05 amRNSHolding(s) in Company
4th Jun 20211:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.